Skip to content
Erudio Health
menu
Clinical trial · no report yet · Phase not applicable

LAP-ABLATE

Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy

We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.

Preliminary discovery

Commentary in our index that names this trial so far

Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.

ChannelFound
X threads14
Podcasts1
X videos1

The trial

ClinicalTrials.gov
Official title
Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy (LAP-ABLATE)
Phase
Phase not applicable
Status
Not yet recruiting
Conditions
Pancreatic Cancer
Interventions
MRIdian
Arms
  • Ablative MRIdian SMART · Experimental
  • No ablative MRIdian SMART · No intervention
Enrollment
267 (estimated)
Primary outcomes
  • Overall Survival (OS)
Sponsor
Viewray Inc.
Start
Jul 2023 (estimated)
Primary completion
Aug 2028 (estimated)
Results posted
No
Registry record
NCT05585554 · updated Oct 19, 2022

Publications

linked from the registry
  • Rudra S, Jiang N, Rosenberg SA, Olsen JR, Roach MC, Wan L, Portelance L, Mellon EA, Bruynzeel A, Lagerwaard F, Bassetti MF, Parikh PJ, Lee PP. Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer. Cancer Med. 2019 May;8(5):2123-2132. doi: 10.1002/cam4.2100. Epub 2019 Apr 1. PubMed 30932367
  • Eaton AA, Karanicolas P, Johnson MChir CD, Bottomley A, Allen PJ, Gonen M. Psychometric Validation of the EORTC QLQ-PAN26 Pancreatic Cancer Module for Assessing Health Related Quality of Life after Pancreatic Resection. JOP. J Pancreas (Online) 2017; 18(1):19-25.